Dr. Farshid Dayyani is a professor of clinical medicine at the Division of Hematology/Oncology, Medicine School of Medicine, University of California, Irvine. He is also a board-certified UCI Health medical oncologist who specializes in the treatment of cancers of the gastrointestinal tract. He earned his MD at the University of Munich (2002) and completed his PhD in Immunology at the University of Munich (2002). He completed a residency in internal medicine at Beth Israel Deaconess Medical Center in Boston, a teaching hospital of Harvard Medical School. He also completed a fellowship in medical oncology at the University of Texas MD Anderson Cancer Center in Houston. His clinical interests include colorectal, stomach, and esophageal cancers, and anal carcinoma. His goal is to bring leading-edge treatments to patients with gastrointestinal cancers through innovative clinical trials and translational research.